| Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography |
| 1.1 - Asymptomatic | 2003 | Singapore | IgE | 105 | 22.800 | |
| 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 2.600 | 20131020, van Rhijn BD
|
| 1.2.1 - Asthma, Diagnosed (Adults) | 2003 | Malaysia | IgE | 94 | 37.000 | |
| 1.2.2 - Asthma, Diagnosed (Children) | 2003 | Malaysia | IgE | 49 | 90.000 | |
| 1.3 - Rhinitis, Diagnosed | 2003 | Singapore | IgE | 124 | 50.000 | |
| 1.4 - Respiratory Symptoms, Diagnosed | 2007 | Singapore | IgE | 494 | 56.300 | |
| 1.4 - Respiratory Symptoms, Diagnosed | 2002 | Thailand | SPT | 95 | 10.500 | |
| 1.4 - Respiratory Symptoms, Diagnosed | 2002 | Thailand | SPT | 85 | 11.760 | 2002, Trakultivakorn M
|
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 12.000 | 20140821, Choi JS
|
| 3.1.1 - Source Sensitized (SPT) | 2004 | Singapore | SPT | 38 | 94.700 | |
| 3.1.1 - Source Sensitized (SPT) | 1999 | Singapore | SPT | 46 | 45.000 | |
| 3.1.1 - Source Sensitized (SPT) | 2003 | Thailand | SPT | 45 | 31.100 | |
| 3.1.1 - Source Sensitized (SPT) | 2003 | United Kingdom | SPT | 12 | 0.000 | |
| 3.2.1 - Source Sensitized (IgE) | 2013 | Brazil | IgE | 35 | 82.860 | 20130228, Dos Carvalho KA
|
| 3.2.1 - Source Sensitized (IgE) | 2013 | Brazil | IgE | 28 | 92.860 | 20130228, Dos Carvalho KA
|
| 3.2.1 - Source Sensitized (IgE) | 2013 | Colombia | IgE | 40 | 59.600 | 20131204, Zakzuk J
|
| 3.2.1 - Source Sensitized (IgE) | 2003 | United Kingdom | SPT | 2 | 0.000 | |
| 5.1.1 - Source Exposed (Symptoms) | 2003 | Malaysia | IgE | 49 | 73.500 | |
| 5.1.1 - Source Exposed (Symptoms) | 2003 | Taiwan | IgE | 146 | 91.800 | |
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2004 | Singapore | IgE | 25 | 100.000 | |
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2008 | China | SPT | 45 | 48.880 | 20081126, Cheong N
|
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2008 | Singapore | SPT | 33 | 84.840 | 20081126, Cheong N
|
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2007 | Colombia | IgE | 90 | 42.200 | 20080220, Jimenez S
|
| 5.3.1 - Source Exposed (Symptoms, IgE) | 1996 | Colombia | IgE | 100 | 47.000 | |
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Singapore | IgE | 177 | 46.000 | 20110221, Kidon MI
|
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Singapore | IgE | 30 | 96.700 | 20100326, Shek LP
|
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Singapore | IgE | 30 | 86.700 | 20100326, Shek LP
|
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2003 | Taiwan | IgE | 80 | 43.300 | |
| 5.7.1 - Source Exposed (Provocation Test - Inhalation) | 2007 | Singapore | IgE | 43 | 97.800 | |
| 6.1 - General Population | 2003 | Barbados | IgE | 481 | 54.300 | |
Loading...
Blo t 5
